Microsoft PowerPoint - KaySavolainenNanotechn
-
Upload
misaelron383 -
Category
Documents
-
view
213 -
download
1
Transcript of Microsoft PowerPoint - KaySavolainenNanotechn
Nanotechnologies and Occupational Health
Kai Savolainen
ICOH SCOM International Congress, Amsterdam, The Netherlands
7-8 April 2011
Challenges of nanomaterials and nanotechnologies for occupational health
• Ongoing technological revolution:– engineered nanomaterials (ENM) allow novel technological innovations, already commonplace in consumer and industrial applications
• Huge impact on the economy and the society
• Lack of accepted safety concepts for ENM– Concerns on the effects of ENM on health of workers and consumers
– Toxic effects of ENM have raised concerns among regulators, academia, media and public
• Potential for deleterious impacts on health
1920 1930 1940 1950 1960 1970 1980 1990 2000
0
2000
4000
6000
8000
10000
12000
0
10
20
30
40
50
60
70
80
90
100
1920 1930 1940 1950 1960 1970 1980 1990 2000 2010
Asbestin käyttö, tonnia/vuosi Mesotelioma/vuosi
20th century: The use of asbestos and its association with the incidence of mesotheliomas
Individual studies
The use of asbestos
Incidence of mesotheliomas
Cross section Cancer latency of 30 years
Nanomaterials are already on the market
David Hawkhurst, PENMore than 500 self-identified nanoproducts are on the market today, and the list is growing rapidly, according to the Project on Emerging Nanotechnologies. However, some warn that not all of these claims may hold up to a test of true nano-ness.
Risk assessment required knowledge on effects: what do we know about toxicological and ecotoxicological effects of various ENP
Exposure data is vital for risk assessment: summary of ENP workplace monitoring studies in 2010 – lack of data a major challenge
Diversity of different nanomaterials complicates the assessment of risks of the materials. Schulte et al.J. Occup. Environ. Med. 2009, in press
Actual ENPs
Studied for
Hazard
Generalizability
Universe of Potential ENPs
Challenge: How to use a limited amount of hazard and exposure data to develop risk management guidance?
Issues in Developing Risk Management Guidance for Nanomaterials
• Vast number of nanomaterials
• Limited hazard information
– Few materials studied
– Few long-term studies
• Diverse occupational exposure scenarios
• Workers are currently exposed
Transport
Commercial
Academic
Incorporation in Products
Maintenance of ProductsManipulation of ProductsApplication of Products - Medical Delivery
Disposal / End of Life
Recycling
Research Laboratories
Warehousing/Maintenance
Waste Handling
Start Up/Scale Up Operations
Transport
Warehousing/Maintenance
Warehousing/Maintenance
Transport
Waste Handling
Manufacturing/Production
Schulte P et al,
Sharpening the
focus on
occupational
safety and health
of nano-
technology.
SJWEH (2009)
Metrics of ENM - challenges for the assessment of exposure and effects of ENM
• Due to small size, mass poorly associates with effects of ENM, other choices for metrics:
– surface area, -chemistry, -structure
– shape and size
– chemical composition
– number concentrations
• Measurement of exposure - current technologies do not allow distinction between background nanoparticles and ENM – setting or controlling of OEL not possible
26/04/2011 13
Airborne Monitoring to Distinguish ENM from Incidental Particles for Environmental Health and Safety. Peters et al., J. Occup. Environ. Hyg. 2009, 6:73–81
Kai Savolainen/21/02/2011
Small Amounts of Zinc from Zinc Oxide Particles in Sunscreens Applied Outdoors Are Absorbed through Human Skin. Gulson et al. Toxicol. Sci. 118(1), 140–149 (2010)
What are the exposure-associated hazards we want to control or prevent
• pulmonary inflammation, other inflammatory effects such as effects on the skin
• genotoxic effects
• effects on circulation
• exposure of the brain and possible consequent hazards etc.
• In the following, some examples
CNT and production of ROS, oxidative stress, and associated toxicity
• CNT may induce inflammation, genotoxicity and cancer, which may be associated and even causally linked with each other
• Oxidative stress may be one of the mechanisms explaining the effects of CNT
Inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice
Shvedova et al., Am J Physiol Lung Cell Mol Physiol 289: L698–L708, 2005.
CNT Genotoxicity: DNA damage and micronuclei induced by carbon nanotubes and graphite nanofibres in human bronchial epithelial cells in vitro. Lindberg et al. Toxicol. Lett. 2009, doi:10.1016/j.toxlet.2008.11.019
A single dose of MWCNT induced asbestos-like changes in peritoneal cavity of mice
• Exposure of mouse peritoneum to MWCNT induce asbestos-like fiber-length dependent morphological alterations in the mesothelium; inflammation & granulomas
• Long rather than short (< 5 um) fibers were likely to induce morphological alterations and inflammation (Poland et al., 2008)
Granuloma formation after intra peritoneal exposure to particles/fibers after 7 days
Long amosite(brown asbestos)
Long MWCNTSample 1
Long MWCNTSample 2
Short MWCNTSample 1
Short MWCNTSample 2
Granuloma response7 days post -installation
Long fibersShort fibers
Poland et al. Nature Nanotech. 2008 Jul;3(7):423-8.
Subpleural fibrosis in mice after MWCNT inhalation
saline aerosol-exposed
MWCNT exposed mice 2 weeks after inhalation
Subpleural fibrotic lesion showing MØ with MWCNT
Ryman-Rasmussen et al. Nature
Nanotech. 4(11):747-751 (2009)
Hazard Identification
“Is there reason to believe this
could be harmful?”
Risk Management
“Develop procedures to minimize
exposures.”
Exposure Assessment
“Will there be exposure in real-world
conditions?”
Risk Characterization
“Is substance hazardous and will
there be exposure?”
Key Elements in Worker Protection
Occupational Exposure Limits (OELs)
• Major tool for prevention of occupational disease
• Long history of use
• Some provisional OELs developed for nanomaterials
Available
Toxicity Data
Suggestive
Qualitative or Semi-
quantitative Hazard or Risk Assessment
Reason by Analogy or
SAR
Quantitative Risk
Assessment
Adequate
Insufficient
Determination of OEL
Control Banding
Performance-Based
Exposure Control Limits
Categorical OELs
Proposed OELs for Engineered Nanoparticles
Nanomaterial Parameter OEL References
General 0.004% risk level Mass-based OEL: 15 OECD [2008]
Titanium Dioxide 0.1 risk level particles <100 nm
0.1 mg/m3 NIOSH [2005]
General Dust 3 mg/m3 BAuA [2009]
Photocopier Toner
Tolerable risk2009 acceptable risk2018 acceptable risk
0.6 mg/m3
0.06 mg/m3
0.006 mg/m3
BAuA [2008]
Biopersistent Granular Materials (Metal Oxides, Others)
Density > 6,000 kg/m3 20,000 particles/cm3 IFA [2009]
Biopersistent Granular Materials
Density < 6,000 kg/m3 40,000 particles/cm3 IFA [2009]
CNTs Exposure risk ratio for asbestos
0.01 f/cm3 IFA [2009]
Nanoscale liquid Mass-based OEL IFA [2009]
Fibrous 3:1; length 75,000 nm 0.01 f/cm3 BSI [2007]
CMAR Mass-based OEL: 10 BSI [2007]
Insoluble Not fibrous Mass-based OEL: 15 BSI [2007]
Soluble Not fibrousNot CMAR
Mass-based OEL: 10 BSI [2007]
Hazard Classification forUltrafine (Nanoscale) TiO2<100 nm
• Weight of evidence suggests tumor response in ultrafine TiO2
– Results from secondary genotoxic mechanism
– Related to physical form of inhaled particle(i.e., particle surface) rather than the chemical compound itself
– Rat tumorigenic data are sufficient and appropriate for making preventive recommendations
• Classification– Potential Occupational Carcinogen
Quantitative Risk Assessment (QRA) Methods to DevelopRecommended Exposure Limits for Inhaled ParticlesBased on Kuempel et al. [2006]
Assume equal risk at equivalent dose
Rodent
Determine tissue-specific dose
Calculate benchmark
dose*
Extrapolate
Working lifetime exposure
concentration
Equivalent tissue
dose
Estimate exposures leading to lung dose
Recommended
exposure limit
Technical feasibility of measurement and control
Adjust for species differences
(e.g. lung surface area)*Dose associated with specified level of risk.
Human
Experimental data of exposure andadverse effect
Measure or model
Dose-response modeling
Ultrafine (Nanoscale) TiO2
• Recommended Exposure Limit
– 0.3 mg/m3 (TWA for up to 10 hrs/day for a working lifetime)
– Estimated to reduce risk of lung cancer below1 in 1,000
Fine TiO2
• Recommended Exposure Level• NIOSH used all tumor data when conducting dose-response modeling
• QRA indicates lifetime risk of lung cancer of1 in 1,000 at 2.4 mg/m3 (95% Lower Confidence Limit)
• 2.4 mg/m3 (TWA for up to 10 hrs/day over a working life) to reduce risks of lung cancerbelow 1 in 1,000
CARBON NANOTUBES
• Several animal studies showed pulmonary fibrosis and granulomatous inflammation from carbon nanotube (CNT) exposure
• Associated with both unpurified and purified CNT (raw metal contaminated)
• Effects occurring at relatively low doses
• Ability of CNT to persist and migrate to pleura
• Genotoxicity
Nanocyl[Ma-Hock et al
2009]
NIOSH [CNT CIB 2010]
Bayer [Pauluhn 2010]
AIST Japan [Kobayashi et al
2009]
OEL
(µg/m
3)
15
30
45
3500
5000
MWCNT2.5 µg/m3
CNT & CNF
7 µg/m3
MWCNT 210 µg/m3
MWCNT50 µg/m3
OEL Development Activities for Carbon Nanotubes
OSHA Carbon black PEL
OSHA Graphite PEL (respirable)
BSI—0.01 f/ml [benchmark exposure limit-BEL] high aspect ratio nanomaterials–established at 1/10 asbestos OEL
Views Towards Engineered Nanoparticles
TimeHazard
ClassificationType of Action
Present “As if” Precautionary
Near Future “Likely to be” Due diligence
Farther Future “Is” Institutionalized
Health Hazard Bands: the approach
established in 1980's
• Industry did not have experience establishing very low OELs
• Industry did not have analytical methods to measure these low exposures
• Assign chemicals into “categories” or “bands”
based on their inherent properties
• Facilitates the implementation of “control bands”
TO REMEMBER:
HAZARD X EXPOSURE = RISK
Risk Assessment/Management Paradigms
Traditional
Risk = (HazardExposureControl)
Tait [2005]
Control Banding for Nanomaterials
Maynard, A.D. [2007]. Nanotechnology: the next big thing, or much ado about nothing? Ann Occ Hyg 51(1):1–12.
Steps to Protect Workers from Hazards of an Emerging Technology
Anticipate & identify potential hazards
Take precautions
Assess effectiveness of precautions
Clarify knowledge of hazards
Determine risks
Clarify risk management practices
Establish standard risk management practices
Continually evaluate evidence & approaches
Epidemiologic research
Occupational health surveillance
Establish exposure registries
Physical Form
Task Duration
Quantity
milligrams
kilograms
15 minutes
8 hours
slurry/suspension highly disperseagglomerated
Factors Influencing Control Selection
Engineered Local
Exhaust Ventilation
Closed Systems
Occupational Health Hazardmild /
reversible
severe /
irreversible